Compare with PLETHICO PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs PLETHICO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES PLETHICO PHARMA ALKEM LABORATORIES/
PLETHICO PHARMA
 
P/E (TTM) x - -1.1 - View Chart
P/BV x 6.3 0.0 37,872.5% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 ALKEM LABORATORIES   PLETHICO PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
PLETHICO PHARMA
Mar-14
ALKEM LABORATORIES/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,589395 402.4%   
Low Rs1,23231 3,936.1%   
Sales per share (Unadj.) Rs417.5604.4 69.1%  
Earnings per share (Unadj.) Rs56.332.5 173.3%  
Cash flow per share (Unadj.) Rs64.751.3 126.1%  
Dividends per share (Unadj.) Rs12.700-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs292.9473.6 61.9%  
Shares outstanding (eoy) m119.5734.08 350.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.40.4 958.3%   
Avg P/E ratio x25.16.6 381.9%  
P/CF ratio (eoy) x21.84.2 525.0%  
Price / Book Value ratio x4.80.5 1,070.0%  
Dividend payout %22.60-   
Avg Mkt Cap Rs m168,6537,262 2,322.3%   
No. of employees `000NANA-   
Total wages/salary Rs m9,1711,596 574.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m49,91520,598 242.3%  
Other income Rs m1,645386 425.8%   
Total revenues Rs m51,56120,984 245.7%   
Gross profit Rs m8,4822,818 301.0%  
Depreciation Rs m1,006642 156.6%   
Interest Rs m6711,593 42.1%   
Profit before tax Rs m8,451969 872.6%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,606-138 -1,160.6%   
Profit after tax Rs m6,7311,107 608.1%  
Gross profit margin %17.013.7 124.2%  
Effective tax rate %19.0-14.3 -133.0%   
Net profit margin %13.55.4 250.9%  
BALANCE SHEET DATA
Current assets Rs m27,06218,877 143.4%   
Current liabilities Rs m15,32411,896 128.8%   
Net working cap to sales %23.533.9 69.4%  
Current ratio x1.81.6 111.3%  
Inventory Days Days6736 185.1%  
Debtors Days Days41198 20.9%  
Net fixed assets Rs m12,6109,861 127.9%   
Share capital Rs m239341 70.2%   
"Free" reserves Rs m34,49012,331 279.7%   
Net worth Rs m35,02716,139 217.0%   
Long term debt Rs m1,2124,706 25.7%   
Total assets Rs m54,38733,146 164.1%  
Interest coverage x13.61.6 846.0%   
Debt to equity ratio x00.3 11.9%  
Sales to assets ratio x0.90.6 147.7%   
Return on assets %13.68.1 167.1%  
Return on equity %19.26.9 280.2%  
Return on capital %24.912.3 202.3%  
Exports to sales %12.921.4 60.6%   
Imports to sales %3.115.2 20.3%   
Exports (fob) Rs m6,4614,402 146.8%   
Imports (cif) Rs m1,5403,136 49.1%   
Fx inflow Rs m6,5634,402 149.1%   
Fx outflow Rs m3,0123,184 94.6%   
Net fx Rs m3,5521,219 291.5%   
CASH FLOW
From Operations Rs m7,2592,437 297.8%  
From Investments Rs m1,864-6,265 -29.8%  
From Financial Activity Rs m-9,2732,490 -372.4%  
Net Cashflow Rs m-150-1,337 11.2%  

Share Holding

Indian Promoters % 66.9 82.7 80.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 4.3 769.8%  
FIIs % 0.0 5.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 7.5 -  
Shareholders   68,381 10,665 641.2%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  FULFORD INDIA  NATCO PHARMA  AJANTA PHARMA  

Compare ALKEM LABORATORIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slips Over 300 Points; Axis Bank & Tech Mahindra Top Losers(12:30 pm)

Share markets in India have extended early losses and are presently trading deep in the red. Barring consumer durables sector, all sectoral indices are trading in red with stocks in the telecom sector.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Sep 17, 2019 01:41 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - STRIDES PHARMA SCIENCE COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS